Month: June 2021

Second primary endpoint added following discussion with the U.S. Food and Drug Administration Successfully meeting either PFS or OS primary endpoints expected to be sufficient for submitting a BLA for potential full FDA approval PFS endpoint readout expected in 2022; BLA submission could be possible one year earlier than previously projected with OS endpoint alone Clinical trial amendment reported in an OVAL Clinical Trial in Progress poster presentation at the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingTEL AVIV, Israel, June 03, 2021 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq: VBLT) today announced a primary endpoint amendment in the OVAL Phase 3 registration-enabling study of VB-111. The clinical trial amendment included a second, separate primary endpoint, of progression free survival (PFS), in addition...

VANCOUVER, British Columbia, June 03, 2021 (GLOBE NEWSWIRE) — Abacus Mining & Exploration Corporation (“Abacus” or the “Company”) (TSXV: AME) wishes to announce the results from a recently completed three-hole drilling program on the Jersey Valley epithermal gold property. The Company intercepted similar gold and silver values to historical drilling, with the targets tested further along strike and at slightly greater depth. The best results were a 12.64 metre interval of 0.053 g/t gold and 0.73 g/t silver, including 1.09 g/t silver over 7.55 metres and 0.19 g/t gold and 3.62 g/t silver over 1.5 m. These types of gold systems are found due to the presence of low, subeconomic precious metal values near surface, and it is possible that the Company did not drill deep enough in this first pass of drilling. Sampling of the drill...

Clinicians affirm need for accurate early-stage diabetic kidney disease risk assessment to improve patient outcomes and reduce healthcare costs NEW YORK, June 03, 2021 (GLOBE NEWSWIRE) — Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) today announced results from a new utility study. The study confirmed the importance of risk assessment testing in addressing treatment ambiguity in the early stages of diabetic kidney disease (DKD) and improving patient engagement and adherence, two major barriers to slowing or preventing DKD progression and preserving kidney health. In clinical studies, KidneyIntelX has shown to accurately predict progression of DKD, suggesting that KidneyIntelX risk assessment could support primary care physicians in making appropriate treatment decisions and slowing or preventing DKD progression. In this qualitative...

Shelby Township, Michigan, June 03, 2021 (GLOBE NEWSWIRE) — Resgreen Group International (OTCPINK: RGGI), a leading mobile robot company, announces the relocation of manufacturing and production headquarters to Shelby Township, Michigan. Resgreen Group International has moved to a larger facility to meet the increasing needs and demands of rapid development and fabrication of current and future products. Working in close proximity with a vital supplier, Atlantic Precision Products, RGGI is able to add a new level of quality, efficiency, and momentum to the growth, development and assembly processes. “We are very excited to be expanding into a larger facility and working closely with Atlantic Precision Products in order to increase efficiency in our production and manufacturing process.” said Parsh Patel, CEO of Resgreen Group...

WARSAW, Ind., June 03, 2021 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the completion of the senior leadership transition, with David Bailey succeeding Mark Throdahl as Chief Executive Officer. Mark Throdahl will remain with the Company as Executive Chairman. “Over the last 10 years, it has been a privilege to work with our remarkable team leading the effort to improve the lives of children suffering from musculoskeletal disorders,” said Mark Throdahl. “As Executive Chairman, I look forward to remaining highly engaged with OrthoPediatrics and its strategy as well as supporting Dave in his new role as CEO. Dave has been an exemplary executive since joining OrthoPediatrics in 2007, and I have every confidence...

ATLANTA, June 03, 2021 (GLOBE NEWSWIRE) — Secureworks® (NASDAQ:SCWX), a global leader in cybersecurity, today announced that Chief Executive Officer Michael R. Cote is retiring as CEO and a member of the Secureworks Board of Directors, effective Sept. 3, 2021. The Secureworks Board of Directors unanimously appointed Wendy K. Thomas, Secureworks’ current President of Customer Success, as the company’s next President and Chief Executive Officer, effective Sept. 3, 2021. “Wendy is a proven and respected leader who has been the driving force of our company’s transformation,” said Mr. Cote. “Her deep knowledge of our business has made her a valued strategic partner for many years, and throughout her tenure she has delivered strong operating results and innovative solutions through a relentless commitment to our customers, our purpose,...

AUSTIN, Texas, June 03, 2021 (GLOBE NEWSWIRE) — Atlas Technical Consultants, Inc. (Nasdaq: ATCX) (“Atlas” or the “Company”), a leading Infrastructure and Environmental services provider, announced today that senior management of the Company will participate in the following investor conferences during the month of June:KeyBanc 2021 Virtual Industrials & Basic Materials Conference, June 4, 2021; UBS 2021 Global Industrials & Transportation Virtual Conference, June 8, 2021; Stifel 2021 Virtual Cross Sector Insight Conference, June 10, 2021; and Lytham Partners Virtual Summer 2021 Investor Conference, June 15, 2021.About Atlas Technical ConsultantsHeadquartered in Austin, Texas, Atlas is a leading provider of Environmental (ENV), Testing, Inspection & Certification (TIC), Engineering & Design (E&D), and...

The partnership will help serve a dire need for surface disinfectant treatments to prevent the spread of highly infectious diseases to vulnerable populations in developing nations VANCOUVER, British Columbia, June 03, 2021 (GLOBE NEWSWIRE) — AREV Nanotech Brands, Inc. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) (“AREV” or the “Company”), a publicly traded life science enterprise, and Germinator, leading sanitizing and disinfecting company, have entered into a definitive agreement to provide the Genesis hypochlorous acid (HOCl) platform of surface disinfection to global public health commodity procurement programs to aid refugees and Internally Displaced Persons (IDPs) throughout Central and South America, Africa, eastern Europe, and Asia. Through their partnership, Germinator grants to AREV exclusive rights to distribute...

WAKEFIELD, Mass., June 03, 2021 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today that it has achieved full patient enrollment in its randomized, double-blind, placebo-controlled Phase 2 clinical trial of Brilacidin for the treatment of moderate-to-severe COVID-19 in hospitalized patients (see NCT04784897). Innovation Pharmaceuticals is developing Brilacidin for treatment of COVID-19 under U.S. FDA Fast Track designation. Complete trial enrollment comprised 120 dosed patients recruited across multiple sites. Final data collection for the last patient enrolled in the study is expected to occur in early August (Study Day 60), which will then be followed by the process of unblinding study data and the reporting of topline study results. “We are pleased...

WIXOM, Mich., June 03, 2021 (GLOBE NEWSWIRE) — Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that members of its executive management team will be presenting at the 2021 LD Micro Invitational XI on June 10th at 2:30pm EDT. The conference will be held in a virtual format. A live webcast of the event will be available from the “Events and Presentations” page in the “Investors” section of the Company’s website at rockwellmed.com. You may also register as an attendee directly to watch the presentation at https://ldmicrojune2021.mysequire.com. A replay of the webcast will be archived on the Company’s website for 30 days following the presentation. About Rockwell Medical...